Can Calcium Channel Blockers Save Stressed-Out Dopaminergic Neurons?
Scientists have long wondered why Parkinson’s disease selectively kills a small group of dopamine-generating neurons...
ALL NEWS
6397 RESULTS
Sort By:
- Most Recent
- Most Commented
Research Brief: AD Risk—Do Bilinguals Buy Time?
Watch your language; it could protect you from Alzheimer’s disease...
All in the “Synuclein” Family?—Baby β Also Causes Neurodegeneration
Move over α-synuclein; your smaller brother wants in on the act...
No Rest for Microglia: These Immune Cells Manage Healthy Synapses
Researchers report that microglia appear to swallow dendritic spines in the visual cortex of healthy mice when they find themselves in 24-hour-dark conditions...
ApoE2 Carriers Have Less Brain Atrophy, AD Pathology in Spinal Fluid
The few people who have an ApoE2 allele enjoy reduced risk of late-onset Alzheimer’s disease...
Clinical Trials on Alzheimer's Disease 2010
Toulouse: Experimental Drug Sensitizes Receptor, Boosts Cognition Clinical Trials on Alzheimer's Disease 2010
Next-Generation Sequencing: Boldly Going Where No Geneticist...
Scientists have hoped that knowledge of human genetics would provide new clues as to why some people get diseases that others do not...
Paper Alert: Negative DHA Trial Fuels Soul-Searching in AD Field
It is touted as brain food, but the polyunsaturated fatty acid DHA failed to slow mental decline in AD patients who took it in pill form for one and a half years...
Insidious Spread of Aβ: More Support for Synaptic Transmission
Does Aβ, the quintessential Alzheimer’s disease protein, multiply from a few seeds and spread through brain networks like kudzu taking over a garden patch?...
Toulouse: Experimental Drug Sensitizes Receptor, Boosts Cognition
A compound that partially activates α7 nicotinic acetylcholine receptors has shown promise at surprisingly low doses in early AD clinical trials...
Indianapolis: Clinical Trials a Ripple, Scientists Hope for a Wave
Many scientists said the progress in identifying the basic biology behind FTDs may soon translate into new therapeutic targets...
Indianapolis: Dissecting the Pathways Behind Frontotemporal Dementia
Recent discoveries of the molecular underpinnings of nearly all frontotemporal dementias have nudged open a door for researchers to begin to unravel disease pathways...
Indianapolis: Neuroimaging Opens Window to Disease, Better Diagnosis
Frontotemporal dementias pose a challenge for diagnosis because numerous overlapping clinical syndromes are associated with the disease...
Aβ Neurotoxicity—Is it the Dimer? No, and Yes
Aβ peptides inhabit the human brain in various sizes and shapes, and an enduring question among Alzheimer’s disease researchers has been, Which of them is neurotoxic?...
International Conference on Frontotemporal Dementias: 2010
Indianapolis: Frontotemporal Dementia Research Comes of Age Indianapolis: Neuroimaging Opens Window to Disease, Better Diagnosis Indianapolis: Dissecting the Pathways Behind Frontotemporal Dementia Indianapolis: Clinical Trials a Ripple, Scientists Hope f
Current Filters
- Date Range : All x